WHO recommended Paxlovid on VedDesivir, as well as Merck Molnupiravir and Merck monoclonal antibodies.
The World Health Organization (WHO) Friday “Highly recommended” The use of the Pafizer Paxlovid antiviral pill in patients with light and moderate coronavirus (COVID-19) for the highest risk of hospitalization. However, the United Nations Health Agency highlighted the challenges of the availability and lack of price transparency in low- and middle-income countries, by raising concerns that these countries are likely to be “pushed at the end of The queue “to access the treatment.
5 things you need to know about ...
